Confined or spread disease-Spread with distant metastasis Posts on Medivizor
Navigation Menu

Confined or spread disease-Spread with distant metastasis Posts on Medivizor

Looking patients with advanced cancer to test a new immunotherapy combination

Posted by on May 31, 2019 in Breast cancer | 0 comments

In a nutshell This phase 1/2 trial will investigate BMS-986253, an experimental drug, in combination with nivolumab (Opdivo) to treat advanced cancer. The main outcomes will be the occurrence of side effects and tumor response. The details Advanced cancers have limited treatment options. New drugs are in development to improve patient prognosis. These...

Read More

Looking for patients with advanced BRAF positive colorectal cancer to test an immunotherapy treatment

Posted by on May 25, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness and safety of encorafenib (Braftovi), binimetinib (Mektovi) and cetuximab (Erbitux) in patients with advanced colorectal cancer. The main outcome to be measured will be tumor response to the treatment. The details Colorectal cancer is the third most common cancer worldwide. A high number of...

Read More

High dose vitamin D supplementation may be associated with improved colorectal cancer outcomes

Posted by on May 19, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated if high-dose vitamin D combined with chemotherapy improves outcomes in patients with metastatic (spread to other parts of the body) colorectal cancer. Researchers suggested that high-dose vitamin D was associated with an improved chance of survival. Some background Vitamin D is associated with the intake of...

Read More

Looking for patients with metastatic colorectal cancer to test a new treatment

Posted by on Apr 24, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness and safety of a combined treatment with pembrolizumab (Keytruda) and binimetinib (Mektovi). The main outcome to be measured is the tumor response to the treatment. This trial is recruiting in the United States and Canada. The details Colorectal cancer is the third most common cancer in the...

Read More

Looking for patients with advanced colorectal cancer to test a new immunotherapy combination

Posted by on Apr 24, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1/2 trial is examining the effectiveness of durvalumab (Imfinzi) and monalizumab to treat patients with colorectal cancer or other solid tumors. The main outcomes to be measured are tumor response to the treatment and side effects. The details Cancer is one of the leading causes of death worldwide. Chemotherapy is only of...

Read More

Looking for participants to test a new vaccine to treat advanced colorectal cancer

Posted by on Apr 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness and toxicity of PolyPEPI1018 vaccine in the treatment of advanced colorectal cancer. The main outcome to be measured is tumor response to the treatment. This trial will be conducted in Italy, and Minnesota, US. The details The standard treatment for metastatic (spread to other parts of the body)...

Read More

Looking for participants to test a new treatment combination for advanced colorectal cancer

Posted by on Apr 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness and safety of treatment with nivolumab (Opdivo) and relatlimab in patients with advanced colorectal cancer. The main outcome to be measured will be tumor response to the treatment. This trial is being conducted in Maryland, US. The details Colorectal cancer is the third most common cancer in the...

Read More

Looking for participants with colorectal cancer and liver metastasis to test a new cancer vaccine

Posted by on Mar 26, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness of mFOLFOX6 (oxaliplatin, leucovorin, fluorouracil) and nivolumab (Opdivo) with and without a new cancer vaccine (CV301) for patients with colorectal cancer that has spread to the liver. The main outcome will be overall survival. This trial is being conducted in California and New Jersey,...

Read More

Looking for participants with metastatic colorectal cancer to try a new treatment combination

Posted by on Mar 26, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is comparing the effectiveness and toxicity of ABT-165 or bevacizumab (Avastin) plus FOLFIRI (irinotecan, leucovorin, fluorouracil) chemotherapy in patients with metastatic (spread to other parts of the body) colorectal cancer. The main outcome to be measured will be tumor response and survival without cancer...

Read More